Switch theme
Sign up to access all valuation multiples
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services predominantly through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operate across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.
2015
24.9K+
LTM Revenue $6.1B
LTM EBITDA $529M
$3.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ardent Health Partners has a last 12-month revenue of $6.1B and a last 12-month EBITDA of $529M.
In the most recent fiscal year, Ardent Health Partners achieved revenue of $6.0B and an EBITDA of $575M.
Ardent Health Partners expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ardent Health Partners valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $5.4B | $6.0B | XXX | XXX | XXX |
| Gross Profit | $4.2B | $4.4B | XXX | XXX | XXX |
| Gross Margin | 77% | 74% | XXX | XXX | XXX |
| EBITDA | $350M | $575M | XXX | XXX | XXX |
| EBITDA Margin | 6% | 10% | XXX | XXX | XXX |
| Net Profit | $189M | $50.3M | XXX | XXX | XXX |
| Net Margin | 3% | 1% | XXX | XXX | XXX |
| Net Debt | $722M | $749M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, Ardent Health Partners's stock price is $13.
Ardent Health Partners has current market cap of $1.8B, and EV of $3.5B.
See Ardent Health Partners trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.5B | $1.8B | XXX | XXX | XXX | XXX | $1.68 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, Ardent Health Partners has market cap of $1.8B and EV of $3.5B.
Ardent Health Partners's trades at 0.6x LTM EV/Revenue multiple, and 6.6x LTM EBITDA.
Analysts estimate Ardent Health Partners's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Ardent Health Partners and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.5B | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 6.1x | XXX | XXX | XXX |
| P/E | 8.5x | XXX | XXX | XXX |
| P/E/Growth | 0.5x | XXX | XXX | XXX |
| EV/FCF | 27.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpArdent Health Partners's NTM/LTM revenue growth is 6%
Ardent Health Partners's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Ardent Health Partners's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Ardent Health Partners's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Ardent Health Partners and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 64% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 16% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 65% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 76% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ardent Health Partners acquired XXX companies to date.
Last acquisition by Ardent Health Partners was XXXXXXXX, XXXXX XXXXX XXXXXX . Ardent Health Partners acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Ardent Health Partners founded? | Ardent Health Partners was founded in 2015. |
| Where is Ardent Health Partners headquartered? | Ardent Health Partners is headquartered in United States of America. |
| How many employees does Ardent Health Partners have? | As of today, Ardent Health Partners has 24.9K+ employees. |
| Who is the CEO of Ardent Health Partners? | Ardent Health Partners's CEO is Mr. Martin J. Bonick. |
| Is Ardent Health Partners publicy listed? | Yes, Ardent Health Partners is a public company listed on NYS. |
| What is the stock symbol of Ardent Health Partners? | Ardent Health Partners trades under ARDT ticker. |
| When did Ardent Health Partners go public? | Ardent Health Partners went public in 2024. |
| Who are competitors of Ardent Health Partners? | Similar companies to Ardent Health Partners include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Ardent Health Partners? | Ardent Health Partners's current market cap is $1.8B |
| What is the current revenue of Ardent Health Partners? | Ardent Health Partners's last 12-month revenue is $6.1B. |
| What is the current EBITDA of Ardent Health Partners? | Ardent Health Partners's last 12-month EBITDA is $529M. |
| What is the current EV/Revenue multiple of Ardent Health Partners? | Current revenue multiple of Ardent Health Partners is 0.6x. |
| What is the current EV/EBITDA multiple of Ardent Health Partners? | Current EBITDA multiple of Ardent Health Partners is 6.6x. |
| What is the current revenue growth of Ardent Health Partners? | Ardent Health Partners revenue growth between 2023 and 2024 was 10%. |
| Is Ardent Health Partners profitable? | Yes, Ardent Health Partners is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
